Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The guard changes.

Literature DB >> 31993959

The guard changes.

Justin J Wilkins^1,2.

Abstract

Mesh：

Year: 2020 PMID： 31993959 DOI： 10.1007/s10928-020-09672-6

Source DB: PubMed Journal: J Pharmacokinet Pharmacodyn ISSN： 1567-567X Impact factor: 2.745

Keyword Cloud
References

× No keyword cloud information.

12 in total

Review 1. Diversity of mechanism-based pharmacodynamic models.

Authors: Donald E Mager; Elzbieta Wyska; William J Jusko
Journal: Drug Metab Dispos Date: 2003-05 Impact factor: 3.922

Review 2. Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.

Authors: Peter L Bonate; Malidi Ahamadi; Nageshwar Budha; Amparo de la Peña; Justin C Earp; Ying Hong; Mats O Karlsson; Patanjali Ravva; Ana Ruiz-Garcia; Herbert Struemper; Janet R Wade
Journal: J Pharmacokinet Pharmacodyn Date: 2016-02-02 Impact factor: 2.745

3. Abstracts accepted for American Conference on Pharmacometrics 2016 (ACoP7).

Authors:
Journal: J Pharmacokinet Pharmacodyn Date: 2016-10 Impact factor: 2.745

4. Data standards for model-informed drug development: an ISoP initiative.

Authors: Andrijana Radivojevic; Brian Corrigan; Nicholas Downie; Robert Fox; Jill Fiedler-Kelly; Huan Liu; Murad Melhem; David Radke; Peter Schaefer; Jing Su; Maciej J Swat; Nathan S Teuscher; Neelima Thanneer; Alice Zong; Justin J Wilkins
Journal: J Pharmacokinet Pharmacodyn Date: 2018-07-25 Impact factor: 2.745

5. Abstracts Accepted for American Conference on Pharmacometrics 2014 (ACoP5), October 11-17, 2014, Las Vegas, Nevada.

Authors:
Journal: J Pharmacokinet Pharmacodyn Date: 2014-10 Impact factor: 2.745

6. Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.

Authors: Klaus Romero; Vikram Sinha; Sandra Allerheiligen; Meindert Danhof; Jose Pinheiro; Naomi Kruhlak; Yaning Wang; Sue-Jane Wang; John-Michael Sauer; J F Marier; Brian Corrigan; James Rogers; H J Lambers Heerspink; Tawanda Gumbo; Peter Vis; Paul Watkins; Tina Morrison; William Gillespie; Mark Forrest Gordon; Diane Stephenson; Debra Hanna; Marc Pfister; Richard Lalonde; Thomas Colatsky
Journal: J Pharmacokinet Pharmacodyn Date: 2014-10-07 Impact factor: 2.745

The guard changes.

Review 1. Diversity of mechanism-based pharmacodynamic models.

Review 2. Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.

3. Abstracts accepted for American Conference on Pharmacometrics 2016 (ACoP7).

4. Data standards for model-informed drug development: an ISoP initiative.

5. Abstracts Accepted for American Conference on Pharmacometrics 2014 (ACoP5), October 11-17, 2014, Las Vegas, Nevada.

6. Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.

7. Abstracts for American conference on pharmacometrics 2017 (ACoP8).

Review 8. Plasma and tissue protein binding of drugs in pharmacokinetics.

9. Comparison of four basic models of indirect pharmacodynamic responses.

10. Physiologic indirect response models characterize diverse types of pharmacodynamic effects.